Thermo Fisher completes $2.8bn acquisition of The Binding Site Group
The acquisition will expand Thermo Fisher Scientific’s speciality diagnostics segment and complements the company’s existing speciality diagnostics offering…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Jan 23
The acquisition will expand Thermo Fisher Scientific’s speciality diagnostics segment and complements the company’s existing speciality diagnostics offering…
23 Dec 22
Abiomed has now become a part of J&J, and will operate as a standalone business within J&J’s MedTech…
21 Dec 22
The acquisition will enhance Olympus’ capabilities to provide advanced AI-powered solutions and data-driven insights that can potentially transform…
14 Dec 22
The acquisition expands Tandem’s type 1 and type 2 addressable market opportunities and complements the family of insulin…
14 Dec 22
Fusion Biotec is a contract engineering and manufacturing firm in Southern California dedicated to the diagnostics and medical…
12 Dec 22
The US-based biomedical engineering company will make an offer to purchase a maximum of up to 65% shares…
05 Dec 22
Natus delivers innovative and trusted solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and…
05 Dec 22
Transaction Includes Acquisition of Bioassay GmbH Subsidiary, Peptide Specialty Laboratories GmbH, a Provider Specializing in the Synthesis and…
23 Nov 22
Biocare Medical and Empire Genomics will bring an expanded offering of solutions to those researching and diagnosing cancer…
16 Nov 22
CardieX's comprehensive suite of heart health solutions to be enhanced by Blumio's next-generation cardiovascular wearable sensor algorithms and…